Literature DB >> 16542835

Imminent ovarian failure in childhood cancer survivors.

G M Lantinga1, A H M Simons, W A Kamps, A Postma.   

Abstract

The aim of this study was to investigate reproductive history and the prevalence of imminent ovarian failure (IOF) in female childhood cancer survivors. Reproductive history and ovarian function were evaluated by questionnaires (n=124) and by measurement of follicle stimulating hormone (FSH) and oestradiol (E2) levels (n=93). IOF was defined as FSH>10 IU/l or E2>0.28 nmol/l on day 3 of the menstrual cycle, or FSH>12.4 IU/l on day 7 of the pill-free interval. IOF was demonstrated in 22.6% of the participants and correlated with age at diagnosis (P<0.005) and age at study (P=0.036). IOF correlated inversely with methotrexate (P=0.046). The incidence of miscarriages (22.7%) and recurrent miscarriages (7.3%) was increased. The male/female (M/F) ratio of the offspring was decreased. In conclusion, female childhood cancer survivors are at risk for IOF. If pregnant, the risk of (recurrent) miscarriages is increased. The M/F ratio in the offspring is decreased.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542835     DOI: 10.1016/j.ejca.2006.01.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study.

Authors:  Raoul C Reulen; Maurice P Zeegers; W Hamish B Wallace; Clare Frobisher; Aliki J Taylor; Emma R Lancashire; Dave L Winter; Mike M Hawkins
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

2.  Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue.

Authors:  Monica M Laronda; Francesca E Duncan; Jessica E Hornick; Min Xu; Jennifer E Pahnke; Kelly A Whelan; Lonnie D Shea; Teresa K Woodruff
Journal:  J Assist Reprod Genet       Date:  2014-05-21       Impact factor: 3.412

3.  Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors.

Authors:  Sana M Salih; Sarah Z Elsarrag; Elizabeth Prange; Karli Contreras; Radya G Osman; Jens C Eikoff; Diane Puccetti
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-06-07       Impact factor: 1.814

4.  Anti-müllerian hormone as a sensitive marker of ovarian function in young cancer survivors.

Authors:  Maryna Krawczuk-Rybak; Elzbieta Leszczynska; Marta Poznanska; Beata Zelazowska-Rutkowska; Jolanta Wysocka
Journal:  Int J Endocrinol       Date:  2013-12-15       Impact factor: 3.257

5.  A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism.

Authors:  Sejal Shah; Nikta Forghani; Eileen Durham; E Kirk Neely
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-20

6.  A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges.

Authors:  Annelies Overbeek; Marleen H van den Berg; Leontien C M Kremer; Marry M van den Heuvel-Eibrink; Wim J E Tissing; Jacqueline J Loonen; Birgitta Versluys; Dorine Bresters; Gertjan J L Kaspers; Cornelis B Lambalk; Flora E van Leeuwen; Eline van Dulmen-den Broeder
Journal:  BMC Cancer       Date:  2012-08-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.